Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 38 (10) , 796.e1-796.e6
Abstract
No abstract availableKeywords
Funding Information
- University of Texas MD Anderson Cancer Center
This publication has 20 references indexed in Scilit:
- Current clinical practice gaps in the treatment of intermediate‐ and high‐risk non‐muscle‐invasive bladder cancer ( NMIBC ) with emphasis on the use of bacillus C almette‐ G uérin ( BCG ): results of an international individual patient data survey ( IPDS )BJU International, 2013
- Radiologic Imaging of Patients With Bladder CancerSeminars in Oncology, 2012
- Comparative Effectiveness of Imaging Modalities for the Diagnosis of Upper and Lower Urinary Tract Malignancy: A Critically Appraised TopicAcademic Radiology, 2012
- Cost Implications of the Rapid Adoption of Newer Technologies for Treating Prostate CancerJournal of Clinical Oncology, 2011
- Contemporary management of low-risk bladder cancerNature Reviews Urology, 2011
- Projections of the Cost of Cancer Care in the United States: 2010-2020JNCI: Journal of the National Cancer Institute, 2011
- Are Referral Centers for Non-Muscle-Invasive Bladder Cancer Compliant to EAU Guidelines? A Report from the Vesical Antiblastic Therapy Italian StudyUrologia Internationalis, 2010
- Treatment of nonmuscle invading bladder cancer: Do physicians in the United States practice evidence based medicine?Cancer, 2009
- Conservative Management of Low Risk Superficial Bladder TumorsJournal of Urology, 2008
- Expectant Management of Small, Recurrent, Noninvasive Papillary Bladder TumorsJournal of Urology, 2003